These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8542892)

  • 21. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
    Bajc M; Ingvar C; Palmer J
    J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.
    Lugtenburg PJ; Krenning EP; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Löwenberg B
    Br J Haematol; 2001 Mar; 112(4):936-44. PubMed ID: 11298588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
    Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
    J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
    Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
    Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Hahn K; Beyer J; Bockisch A
    J Nucl Med; 1995 Apr; 36(4):550-4. PubMed ID: 7699440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
    Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
    J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
    van den Anker-Lugtenburg PJ; Heule F; Vanhagen PM; van Joost T; Oei HY; Löwenberg B; Krenning EP
    J Am Acad Dermatol; 1996 Jun; 34(6):985-93. PubMed ID: 8647992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced bilateral somatostatin receptor expression in mediastinal lymph nodes ("chimney sign") in occult metastatic medullary thyroid cancer: a typical site of tumour manifestation?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Becker H; Becker W
    Eur J Nucl Med; 1997 Feb; 24(2):184-91. PubMed ID: 9021116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor scintigraphy of non-neuroendocrine cancers with In-111 pentetreotide.
    Limouris GS; Rassidakis A; Kondi-Paphiti A; Triantafyllou N; Manetou A; Gennatas K; Vitoratos N; Gregoriou O; Stavraka A; Vlahos L
    Hybridoma; 1997 Feb; 16(1):133-7. PubMed ID: 9085140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
    Nikpoor N; Aliabadi P; Diaz L; Mannting F
    Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
    Jamar F; Fiasse R; Leners N; Pauwels S
    J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
    Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
    J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
    Lee JD; Kim DI; Lee JT; Chang JW; Park CY
    J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptor scintigraphy of malignant lymphoma--current status.
    Serafini AN
    Yale J Biol Med; 1997; 70(5-6):555-9. PubMed ID: 9825483
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
    J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
    Bares R; Galonska P; Dempke W; Handt S; Büll U; Osieka R
    Horm Metab Res Suppl; 1993; 27():56-8. PubMed ID: 8330873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.